GOP Florida Senator Rubio Asks Pfizer CEO About Virus Mutations Exposed By Project Veritas

Republican politician wants answers about the company's alleged manipulation of viruses

Image Credits: infowars.

Senator Marco Rubio (R-FL) sent a letter to Pfizer CEO Albert Bourla on Thursday, asking for more information about the latest Project Veritas undercover report where a Pfizer executive said the company is making viruses more potent.

The Senator asked if Pfizer is conducting gain-of-function research under the guise of a term called, “directed evolution,” research to mutate the SARS-CoV-2 virus.

The company is allegedly trying to create more potent variants of the virus in order to make vaccines for potential future variants.

In his message to Bourla, Rubio began by explaining he’d seen the Veritas video of Pfizer Director of Research and Development Jordon Walker making “troubling” claims about the company’s research.

“As has been proven time and time again, attempts to mutate a virus, particularly one as potent as COVID, are dangerous,” he wrote. “If the claims detailed in the video are true, Pfizer has put its desire for profit over the concern of national and global health and must hold itself accountable.”

Senator Rubio also noted the employee referred to Covid as a “cash cow” and insinuated government regulators give Pfizer drugs a pass because they know they’ll get lucrative jobs with Big Pharma after leaving their positions.

The Florida politician provided the following six questions for the Pfizer CEO to address.

Infowars will report back on this subject if Bourla decides to answer Senator Rubio’s important questions.

Don’t miss R.C. Maxwell of Project Veritas appearing on The Alex Jones Show Thursday for an exclusive breakdown of the Pfizer executive’s admissions.

Unlike legacy media outlets, Infowars relies on YOUR SUPPORT to remain on air.

In order to keep us afloat, visit the Infowars Store to purchase great products such as dietary supplements, books, t-shirts, survival gear and much more.